Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 32999-33000 [2014-13345]

Download as PDF Federal Register / Vol. 79, No. 110 / Monday, June 9, 2014 / Notices development activities, as specified in its original notification. More detail regarding these changes can be found at www.asme.org. On September 15, 2004, ASME filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on October 13, 2004 (69 FR 60895). The last notification was filed with the Department on January 10, 2014. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on February 20, 2014 (79 FR 9767). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2014–13338 Filed 6–6–14; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division ehiers on DSK2VPTVN1PROD with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—ASTM International Standards Notice is hereby given that, on May 7, 2014, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), ASTM International (‘‘ASTM’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing additions or changes to its standards development activities. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, ASTM has provided an updated list of current, ongoing ASTM standards activities originating between February 2014 and May 2014 designated as Work Items. A complete listing of ASTM Work Items, along with a brief description of each, is available at https://www.astm.org. On September 15, 2004, ASTM filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on November 10, 2004 (69 FR 65226). The last notification was filed with the Department on February 27, 2014. A notice was published in the Federal VerDate Mar<15>2010 15:08 Jun 06, 2014 Jkt 232001 Register pursuant to Section 6(b) of the Act on March 27, 2014 (79 FR 17181). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2014–13344 Filed 6–6–14; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cooperative Research Group on Ros-Industrial ConsortiumAmericas Notice is hereby given that, on April 30, 2014, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Southwest Research Institute—Cooperative Research Group on ROS-Industrial Consortium-Americas (‘‘RIC-Americas’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the venture are: ABB–US Corporation Research, Windsor, CT; BMW AG, Munich, Germany; The Boeing Company, Seal Beach, CA; Cessna Aircraft Company, a Textron Company, Wichita, KS; Deere & Company, Moline, IL; EWI, Columbus, OH; Ford Motor Company, Livonia, MI; HDT Robotics, Inc., Fredericksburg, VA; IDEXX Laboratories, Westbrook, ME; National Institute of Standards and Technology, Gaithersburg, MD; National Research Council Canada, Montreal, Quebec, CANADA; OmnicO AGV, Inc., Sterling Heights, MI; Shanghai Shou-Elin Robot Technology Co., Ltd., Shanghai, PEOPLE’S REPUBLIC OF CHINA; Spirit Aero Systems, Inc., Wichita, KS; University of Texas at Arlington, Arlington, TX; The Department of Mechanical Engineering, UT Austin, Austin, TX; Willow Garage, Inc., Menlo Park, CA; and Yaskawa America, Inc., Motoman Robotics Division, Miamisburg, OH. The general area of RIC-America’s planned activity is to develop an application roadmap for ROS-Industrial, set near-term technical goals, and participate in member-initiated Focused PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 32999 Technical Projects (FTP), further supporting the developer community through training, road mapping, events, and technical support. The Robot Operating System (ROS) is an opensource software project that provides a common framework for robotic applications. ROS is being used extensively by the research community for service robotics; its technology can now be applied to industrial/ manufacturing robotics through ROSIndustrial (ROS–I). ROS–I is a repository of ROS drivers and algorithms for industrial robots, sensors, and automation hardware. It enables new applications like unstructured manipulation including advanced perception for identifying robot work pieces (reducing the need for costly hard tooling); dynamic path planning that adapts to the environment in real time and creates collision-free trajectories, mobile manipulation, which enables larger workspaces and more flexible operations. RIC-Americas will focus on the needs of industrial robot users and will accelerate the further development of ROS-Industrial. Patricia A. Brink, Director of Civil Enforcement Antitrust Division. [FR Doc. 2014–13339 Filed 6–6–14; 8:45 am] BILLING CODE DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical Technology Enterprise Consortium Notice is hereby given that, on May 9, 2014, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), the Medical Technology Enterprise Consortium (‘‘MTEC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the venture are: Biohealth Innovation Inc., Rockville, MD; Consortia to Improve Medicine (CIMIT), Boston, MA; Florida Atlantic University, Boca Raton, FL; Indiana University, Bloomington, IN; E:\FR\FM\09JNN1.SGM 09JNN1 33000 Federal Register / Vol. 79, No. 110 / Monday, June 9, 2014 / Notices Institute for Systems Biology, Seattle, WA; Jade Therapeutics, Inc., Salt Lake City, UT; Johns Hopkins Technology Transfer, Baltimore, MD; KAI Research Inc. (KAI), Rockville, MD; Human Effects Modeling, Advanced Technology Inc., L–3 Communications, San Diego, CA; Maryland Technology Development Corp. (TEDCO), Columbia, MD; Institute for Collaborative Biotechnologies, University of California, Santa Barbara, CA; and Center for Military Medical Research, University of Pittsburgh, Pittsburgh, PA. The general area of MTEC’s planned activity is (a) to enter into a Section 845 Other Transactions Agreement (The OT Agreement) with U.S. Army Medical Research and Materiel Command (the Government) for the funding of certain research, development, and commercialization to be conducted, in partnership with the Government, the Consortium, and Consortium Members, to enhance the medical knowledge and life cycle management of the medical program and to enable the Government to better protect, treat, and optimize Warfighter health and performance across the full spectrum of operations; (b) participate in establishment of sound technical and programmatic performance goals based on the needs and requirements of the Government’s Technology Objectives and other mission requirements, (c) create programs and secure funding; (d) provide a unified voice to effectively articulate the strategically important role that military medical technologies play in current and future military operations; and (e) maximize the utilization of the Government and member capabilities and resources to effectively develop critical processes, procedures, drugs, vaccines, and devices that can be transitioned and commercialized for both military and civilian use. Patricia A. Brink, Director of Civil Enforcement Antitrust Division. [FR Doc. 2014–13345 Filed 6–6–14; 8:45 am] BILLING CODE DEPARTMENT OF LABOR ehiers on DSK2VPTVN1PROD with NOTICES Office of the Secretary Authority: 44 U.S.C. 3507(a)(1)(D). Agency Information Collection Activities; Submission for OMB Review; Comment Request; Mine Accident, Injury, and Illness Report and Quarterly Mine Employment and Coal Production Report ACTION: Notice. VerDate Mar<15>2010 15:08 Jun 06, 2014 The Department of Labor (DOL) is submitting the Mine Safety and Health Administration (MSHA) sponsored information collection request (ICR) titled, ‘‘Mine Accident, Injury, and Illness Report and Quarterly Mine Employment and Coal Production Report,’’ to the Office of Management and Budget (OMB) for review and approval for continued use, without change, in accordance with the Paperwork Reduction Act of 1995 (PRA), 44 U.S.C. 3501 et seq. Public comments on the ICR are invited. DATES: The OMB will consider all written comments that agency receives on or before July 9, 2014. ADDRESSES: A copy of this ICR with applicable supporting documentation; including a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained free of charge from the RegInfo.gov Web site at https:// www.reginfo.gov/public/do/ PRAViewICR?ref_nbr=201403-1219-001 (this link will only become active on the day following publication of this notice) or by contacting Michel Smyth by telephone at 202–693–4129, TTY 202– 693–8064, (these are not toll-free numbers) or by email at DOL_PRA_ PUBLIC@dol.gov. Submit comments about this request by mail or courier to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for DOL– MSHA, Office of Management and Budget, Room 10235, 725 17th Street NW., Washington, DC 20503; by Fax: 202–395–6881 (this is not a toll-free number); or by email: OIRA_ submission@omb.eop.gov. Commenters are encouraged, but not required, to send a courtesy copy of any comments by mail or courier to the U.S. Department of Labor–OASAM, Office of the Chief Information Officer, Attn: Departmental Information Compliance Management Program, Room N1301, 200 Constitution Avenue NW., Washington, DC 20210; or by email: DOL_PRA_PUBLIC@dol.gov. FOR FURTHER INFORMATION CONTACT: Contact Michel Smyth by telephone at 202–693–4129, TTY 202–693–8064, (these are not toll-free numbers) or by email at DOL_PRA_PUBLIC@dol.gov. SUMMARY: Jkt 232001 This ICR seeks to extend PRA authority for the Mine Accident, Injury, and Illness Report and Quarterly Mine Employment and Coal Production Report information collection. The reporting and recordkeeping provisions in regulations 30 CFR part 50, Notification, SUPPLEMENTARY INFORMATION: PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 Investigation, Reports and Records of Accidents, Injuries and Illnesses, Employment and Coal Production in Mines, are essential elements in the MSHA’s Congressional mandate to reduce work-related injuries and illnesses among the nation’s miners. Accident, injury, and illness data, when correlated with employment and production data, provide information that allows the MSHA to improve its safety and health enforcement programs, focus its education and training efforts, and establish priorities for its technical assistance activities in mine safety and health. Maintaining a current database allows the MSHA to identify and direct increased attention to those mines, industry segments, and geographical areas where hazardous trends are developing. This could not be done effectively using historical data. The information collected under part 50 is the most comprehensive and reliable occupational data available concerning the mining industry. The Federal Mine Safety and Health Act of 1977 authorizes this information collection. See 30 U.S.C. 813(h). This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless it is approved by the OMB under the PRA and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of law, no person shall generally be subject to penalty for failing to comply with a collection of information that does not display a valid Control Number. See 5 CFR 1320.5(a) and 1320.6. The DOL obtains OMB approval for this information collection under Control Number 1219–0007. OMB authorization for an ICR cannot be for more than three (3) years without renewal, and the current approval for this collection is scheduled to expire on July 31, 2014. The DOL seeks to extend PRA authorization for this information collection for three (3) more years, without any change to existing requirements. The DOL notes that existing information collection requirements submitted to the OMB receive a month-to-month extension while they undergo review. For additional substantive information about this ICR, see the related notice published in the Federal Register on February 27, 2014 (79 FR 11133). Interested parties are encouraged to send comments to the OMB, Office of Information and Regulatory Affairs at the address shown in the ADDRESSES section within 30 days of publication of E:\FR\FM\09JNN1.SGM 09JNN1

Agencies

[Federal Register Volume 79, Number 110 (Monday, June 9, 2014)]
[Notices]
[Pages 32999-33000]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-13345]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on May 9, 2014, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), the Medical Technology Enterprise 
Consortium (``MTEC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
(1) the identities of the parties to the venture and (2) the nature and 
objectives of the venture. The notifications were filed for the purpose 
of invoking the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances.
    Pursuant to Section 6(b) of the Act, the identities of the parties 
to the venture are: Biohealth Innovation Inc., Rockville, MD; Consortia 
to Improve Medicine (CIMIT), Boston, MA; Florida Atlantic University, 
Boca Raton, FL; Indiana University, Bloomington, IN;

[[Page 33000]]

Institute for Systems Biology, Seattle, WA; Jade Therapeutics, Inc., 
Salt Lake City, UT; Johns Hopkins Technology Transfer, Baltimore, MD; 
KAI Research Inc. (KAI), Rockville, MD; Human Effects Modeling, 
Advanced Technology Inc., L-3 Communications, San Diego, CA; Maryland 
Technology Development Corp. (TEDCO), Columbia, MD; Institute for 
Collaborative Biotechnologies, University of California, Santa Barbara, 
CA; and Center for Military Medical Research, University of Pittsburgh, 
Pittsburgh, PA.
    The general area of MTEC's planned activity is (a) to enter into a 
Section 845 Other Transactions Agreement (The OT Agreement) with U.S. 
Army Medical Research and Materiel Command (the Government) for the 
funding of certain research, development, and commercialization to be 
conducted, in partnership with the Government, the Consortium, and 
Consortium Members, to enhance the medical knowledge and life cycle 
management of the medical program and to enable the Government to 
better protect, treat, and optimize Warfighter health and performance 
across the full spectrum of operations; (b) participate in 
establishment of sound technical and programmatic performance goals 
based on the needs and requirements of the Government's Technology 
Objectives and other mission requirements, (c) create programs and 
secure funding; (d) provide a unified voice to effectively articulate 
the strategically important role that military medical technologies 
play in current and future military operations; and (e) maximize the 
utilization of the Government and member capabilities and resources to 
effectively develop critical processes, procedures, drugs, vaccines, 
and devices that can be transitioned and commercialized for both 
military and civilian use.

Patricia A. Brink,
Director of Civil Enforcement Antitrust Division.
[FR Doc. 2014-13345 Filed 6-6-14; 8:45 am]
BILLING CODE

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.